|
1.
|
|
9 p, 1.3 MB |
Lymphangioleiomyomatosis : Searching for potential biomarkers
/
Revilla-López, Eva (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Ruiz de Miguel, Victoria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
López-Meseguer, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Berastegui García, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Boada-Pérez, Meritxell (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Mendoza-Valderrey, Alberto (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Arjona-Peris, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Zapata-Ortega, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Monforte, Víctor (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Bravo Masgoret, Carles (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Roman, Antonio (Instituto de Salud Carlos III) ;
Gómez-Ollés, Susana (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Sáez-Giménez, Berta (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Vascular endothelial growth factor-D (VEGF-D) is the most commonly used biomarker for diagnosing lymphangioleiomyomatosis (LAM). However, lung biopsy is often necessary as well; therefore, defining new biomarkers for LAM is crucial. [...]
2023 -  10.3389/fmed.2023.1079317
Frontiers in Medicine, Vol. 10 (february 2023)
|
|
|
2.
|
|
10 p, 505.0 KB |
Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study)
/
Monforte, Arnau (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Los-Arcos, Ibai (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Martín-Gómez, Maria Teresa (Hospital Universitari Vall d'Hebron) ;
Campany-Herrero, David (Hospital Universitari Vall d'Hebron) ;
Sacanell, Judith (Hospital Universitari Vall d'Hebron) ;
Berastegui García, Cristina (Hospital Universitari Vall d'Hebron) ;
Márquez-Algaba, Ester (Hospital Universitari Vall d'Hebron) ;
Sempere, Abiu (Hospital Universitari Vall d'Hebron) ;
Nuvials, Xavier (Hospital Universitari Vall d'Hebron) ;
Deu, Maria (Hospital Universitari Vall d'Hebron) ;
Castells, Lluís (Hospital Universitari Vall d'Hebron) ;
Moreso, Francesc (Hospital Universitari Vall d'Hebron) ;
Bravo Masgoret, Carles (Hospital Universitari Vall d'Hebron) ;
Gavaldà, Joan (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Len, Oscar (Universitat Autònoma de Barcelona. Departament de Medicina)
Isavuconazole (ISA) is an alternative treatment for spp. and other fungal infections, but evidence regarding its use in solid organ transplant recipients (SOTR) is scarce. All SOTR who received ISA for treatment of a fungal infection (FI) at our center from December 2017 to January 2021 were included. [...]
2022 - 10.1128/spectrum.01784-21
Microbiology Spectrum, Vol. 10 Núm. 1 (february 2022)
|
|
|
3.
|
|
|
4.
|
|
9 p, 1.2 MB |
Long-term results of sirolimus treatment in lymphangioleiomyomatosis : a single referral centre experience
/
Revilla-López, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Berastegui García, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Méndez, Alejandra (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sáez-Giménez, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ruiz de Miguel, Victoria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
López-Meseguer, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Monforte, Víctor (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Bravo Masgoret, Carles (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Pujana, Miguel Angel (Institut d'Investigació Biomèdica de Bellvitge) ;
Ramon, Maria Antonia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gómez-Ollés, Susana (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Roman, Antonio (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Universitat Autònoma de Barcelona
There are few published data on long-term treatment with sirolimus in lymphangioleiomyomatosis (LAM). The objective of this study was to describe the long-term effect of sirolimus in a series of LAM patients followed up in a referral centre, focusing on pulmonary function. [...]
2021 - 10.1038/s41598-021-89562-0
Scientific reports, Vol. 11 (may 2021)
|
|
|
5.
|
|
14 p, 1.1 MB |
Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation
/
Berastegui García, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gómez-Ollés, Susana (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Mendoza-Valderrey, Alberto (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pereira-Veiga, Thais (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Culebras Amigo, Mario (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Monforte, Víctor (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sáez-Giménez, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
López-Meseguer, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sintes-Permanyer, Helena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ruiz de Miguel, Victoria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bravo Masgoret, Carles (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sacanell, Judith (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ramon, María-Antonia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Romero, Laura (Hospital Universitari Vall d'Hebron) ;
Deu, Maria (Hospital Universitari Vall d'Hebron) ;
Román, Antonio (Román Broto) (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
KL-6 is an antigen produced mainly by damaged type II pneumocytes that is involved in interstitial lung disease. Chronic lung allograft dysfunction (CLAD) after lung transplantation (LT) is a major concern for LT clinicians, especially in patients with restrictive allograft syndrome (RAS). [...]
2020 - 10.1371/journal.pone.0226488
PloS one, Vol. 15 (january 2020)
|
|
|
6.
|
|
9 p, 776.9 KB |
Near-normal aerobic capacity in long-term survivors after lung transplantation
/
Sáez-Giménez, Berta (Hospital Universitari Vall d'Hebron) ;
Barrecheguren, Miriam (Hospital Universitari Vall d'Hebron) ;
Ramon, Maria Antònia (Hospital Universitari Vall d'Hebron) ;
Gomez-Garrido, Alba (Hospital Universitari Vall d'Hebron) ;
Bravo Masgoret, Carles (Hospital Universitari Vall d'Hebron) ;
Monforte, Víctor (Hospital Universitari Vall d'Hebron) ;
López-Meseguer, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Berastegui García, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Revilla-López, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Romero, Christian (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Laporta, Rosalía (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Fernández-Rozas, Sonia (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Redel-Montero, Javier (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Solé, Amparo (Hospital Universitari i Politècnic La Fe (València)) ;
de la Torre, Mercedes (Complejo Hospitalario Universitario de A Coruña) ;
Puente, Luis (Hospital General Universitario Gregorio Marañón) ;
Roman, Antonio (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Gómez-Ollés, Susana (Hospital Universitari Vall d'Hebron) ;
Ojanguren, Iñigo (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
The aim of this study was to elucidate whether long-term LT survivors with normal spirometry achieve normal exercise capacity, and to identify predictive factors of exercise capacity. This was a cross-sectional multicentre study, where bilateral LT recipients who survived at least 10 years after LT, with normal spirometry, no diagnosis of CLAD and modified Medical Research Council dyspnoea degree ≤2 underwent cardiopulmonary exercise testing (CPET). [...]
2021 - 10.1183/23120541.00381-2020
ERJ Open Research, Vol. 7 (february 2021)
|
|
|
7.
|
|
7 p, 514.3 KB |
In Vivo Assessment of Pulmonary Arterial Wall Fibrosis by Intravascular Optical Coherence Tomography in Pulmonary Arterial Hypertension : A New Prognostic Marker of Adverse Clinical Follow-Up
/
Domingo Ribas, Enric (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Grignola, Juan C. (Universidad de la República (Montevideo, Uruguai). Departamento de Fisiopatología) ;
Aguilar Torres, Río (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Montero, María Angeles (Hospital Universitari Vall d'Hebron) ;
Arredondo, Christian (Hospital Universitari Vall d'Hebron) ;
Vázquez, Manuel (Hospital Universitari Vall d'Hebron) ;
López-Messeguer, Manuel (Hospital Universitari Vall d'Hebron) ;
Bravo Masgoret, Carles (Hospital Universitari Vall d'Hebron) ;
Bouteldja, Nadia (Hospital Universitari Vall d'Hebron) ;
Hidalgo, Cristina (Hospital Universitari Vall d'Hebron) ;
Roman, Antonio (Hospital Universitari Vall d'Hebron)
The aim is to correlate pulmonary arterial (PA) remodeling estimated by PA fibrosis in PA hypertension (PAH) with clinical follow-up. Histology of PA specimens is also performed. 19 patients, aged 54±16 (4 men), functional class II-III were studied with right heart catheterization, PA Intravascular Ultrasound and optical coherence tomography (OCT) in inferior lobe segment. [...]
2013 - 10.2174/1874306401307010026
The Open Respiratory Medicine Journal, Vol. 7 (april 2013) , p. 26-32
|
|
|
8.
|
|
3 p, 2.3 MB |
Platelet Thromboembolism after Lung Transplantation
/
Bravo Masgoret, Carles (Hospital Universitari Vall d'Hebron) ;
Majó Masferrer, Joaquim (Freeman Hospital) ;
Ruiz Mori, Fernando (Hospital Universitari Vall d'Hebron) ;
Muntaner, Laura (Hospital Universitari Vall d'Hebron) ;
Monforte, Víctor (Hospital Universitari Vall d'Hebron) ;
Solé, Joan (Hospital Universitari Vall d'Hebron) ;
Morell Brotad, Ferran, 1944- (Hospital Universitari Vall d'Hebron) ;
Román, Antonio (Román Broto) (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Lung transplant patients have an increased risk of pulmonary embolism which is often associated with hypercoagulability disorders. We present a case of sudden death resulting from pulmonary intravascular platelet thromboembolism following a single-lung transplant.
2009 - 10.1155/2009/650703
Journal of Transplantation, Vol. 2009 (April 2009) , art. 650703
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
